Journal
MOLECULES AND CELLS
Volume 38, Issue 6, Pages 482-495Publisher
KOREAN SOC MOLECULAR & CELLULAR BIOLOGY
DOI: 10.14348/molcells.2015.0118
Keywords
ceramide; leukemia; lymphoma; sphingolipid; sphingomyelin
Categories
Funding
- Takeda Science Foundation
- Sharome Co., Ltd.
- ONO Pharmaceutical Co., Ltd.
- JSPS KAKENHI [21890144, 25870853]
- Strategic Research Foundation from Ministry of Education, Culture, Sport, Science, and Technology (MEXT) [S1201004, H2012-16]
- SENSHIN Medical Research Foundation
- Mizutani Foundation for Glycoscience
- Collaborative Research from Kanazawa Medical University [C2012-4, C2013-1]
- Grants-in-Aid for Scientific Research [25870853, 21890144] Funding Source: KAKEN
Ask authors/readers for more resources
Sphingolipids such as ceramide, sphingosine-1-phosphate and sphingomyelin have been emerging as bioactive lipids since ceramide was reported to play a role in human leukemia HL-60 cell differentiation and death. Recently, it is well-known that ceramide acts as an inducer of cell death, that sphingomyelin works as a regulator for microdomain function of the cell membrane, and that sphingosine-1-phosphate plays a role in cell survival/proliferation. The lipids are metabolized by the specific enzymes, and each metabolite could be again returned to the original form by the reverse action of the different enzyme or after a long journey of many metabolizing/synthesizing pathways. In addition, the metabolites may serve as reciprocal bio-modulators like the rheostat between ceramide and sphingosine-1-phosphate. Therefore, the change of lipid amount in the cells, the subcellular localization and the downstream signal in a specific subcellular organelle should be clarified to understand the pathobiological significance of sphingolipids when extracellular stimulation induces a diverse of cell functions such as cell death, proliferation and migration. In this review, we focus on how sphingolipids and their metabolizing enzymes cooperatively exert their function in proliferation, migration, autophagy and death of hematopoetic cells, and discuss the way developing a novel therapeutic device through the regulation of sphingolipids for effectively inhibiting cell proliferation and inducing cell death in hematological malignancies such as leukemia, malignant lymphoma and multiple myeloma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available